Fig. 7

Overexpression of VSIG2 was associated with poor prognosis of PDAC patients. A Western blotting was performed on 12 pairs of pancreatic and para-cancerous tissues collected from PDAC patients, when GAPDH was served as a loading control. B 3 pairs of tumor and para-tumor tissues collected from PDAC patients were compared by immunohistochemistry (IHC) assay. C Scatter diagram of staining index about 12 pairs PDAC and adjacent tissue samples using 12-tier IHC scoring. D Overall survival curve was drawn through observing and recording the condition of PDAC patients for 43 months, while all PDAC patients were divided into two groups by VSIG2 expression level. E Disease-free survival probability of PDAC patients with different expression level of VSIG2 was acquired by Kaplan-Meier (https://kmplot.com/analysis/) database. F Forest plot of univariate Cox analysis regarding to multiple parameters. G Forest plot of multivariate Cox analysis regarding to multiple parameters